Effects of ROFLUMILAST on markers of subclinical atherosclerosis In stable COPD; the ELASTIC-trial
Phase of Trial: Phase II
Latest Information Update: 04 Sep 2017
At a glance
- Drugs Roflumilast (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- Acronyms ELASTIC
- 24 May 2016 Status changed from active, no longer recruiting to completed.
- 21 Sep 2015 Planned End Date changed from 1 Sep 2014 to 1 Jan 2016 as reported by ClinicalTrials.gov record.
- 21 Sep 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.